Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-31

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naloxone hydrochloride from Hospira, a generic opioid antagonist.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)